Segments - Canada Respiratory Devices Market by Diagnostic and Monitoring Devices (Capnographs, Pulse Oximeters, Spirometers, Peak Flow Meters, Sleep Test Devices, and Others), Therapeutic Devices (Nebulizers, CPAP Devices, Inhalers, Oxygen Concentrators, Humidifiers, Ventilators, BiPAP Devices, and Others), Disposables (Breathing Circuit, Masks, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The Canada respiratory devices market size is expected to register at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising number of respiratory disease patients.
Respiratory diseases affect the breathing organs and tissues of the individual by making gas exchange difficult. They directly affect the normal functioning of the respiratory tract including the trachea, alveoli, bronchi, pleurae, bronchioles, pleural cavity, and muscles of respiration. Respiratory diseases range from mild diseases such as common cold to the life-threatening disorders such as lung cancer. The most common types of respiratory diseases includes obstructive lung diseases, restrictive lung diseases, chronic respiratory diseases, respiratory tract infections, malignant tumors, pleural cavity diseases, pulmonary vascular diseases, and neonatal diseases. Therefore, the respiratory devices are most commonly use by the patients suffering from respiratory disorders.
The respiratory device, also known as as respirator, is designed to protect the wearer from inhaling hazardous atmospheric gases and particulate. The air-purifying respirator is used to obtain the respirable air by filtering a contaminated air in the atmosphere. On the other hand, the air-supplied respirators are used as alternatives for the supply of breathable air. Air-purifying respirators are inexpensive, disposable, and single-use face masks, also called gas mask. A wide range of industries use respirators including healthcare & pharmaceuticals, oil & gas industries, manufacturing industries, mining industry, cement production industries, textile industry, and defense & public safety services.
The COVID-19 pandemic has affected almost every industry including the healthcare industry. The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems for the patients having respiratory disorders. Therefore, the large scale manufacturing of critical care devices for the patients having respiratory disorders has fuel the expansion of the market during the pandemic situations. Furthermore, the outbreak of coronavirus disease has resulted in long-term association between healthcare and non-healthcare industries to manufacture respiratory care devices. This resulted into many opportunities for the expansion of respiratory devices market.
The report on the Canada respiratory devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Respiratory Devices Market - Canada Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Diagnostic and Monitoring Devices (Capnographs, Pulse Oximeters, Spirometers, Peak Flow Meters, Sleep Test Devices, and Others), Therapeutic Devices (Nebulizers, CPAP Devices, Inhalers, Oxygen Concentrators, Humidifiers, Ventilators, BiPAP Devices, and Others), and Disposables (Breathing Circuit, Masks, and Others) |
Country |
Canada |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Masimo Corporation; Medtronic plc; ResMed Inc.; Philips Healthcare; and GE Healthcare |
Based on diagnostic and monitoring devices, the market is fragmented into capnographs, pulse oximeters, spirometers, peak flow meters, sleep test devices, and others. The spirometer segment is projected to hold a major market share during the projected period due to increasing prevalence of chronic respiratory diseases among adults and children along with the rising demand for digital spirometers in the country. On the other hand, the oximeters segment is anticipated to grow at a rapid pace during the projected period owing to the growing technological advancements for the development of upgraded oximeters.
On the basis of therapeutic devices, the Canada respiratory devices market is segregated into nebulizers, CPAP devices, inhalers, oxygen concentrators, humidifiers, ventilators, BiPAP devices, and others. The inhalers segment is expected to expand at a significant CAGR during the forecast period owing to the increasing number of asthmatic patients in the country. Moreover, wide range use of inhalers in the treatment of major respiratory ailments is expected to promote the expansion of the market segment in the coming years. On the other hand, the ventilators segment is expected to boost the growth of the market segment during the forecast period due to increasing hospitalization of cardiovascular respiratory disease patients along with surge in demand for personal protection equipment and ventilators in the country.
In terms of disposables, the market is classified into breathing circuit, masks, and others. The breathing circuit segment is anticipated to constitute a major market share during the forecast period owing to increase in the number of respiratory surgeries, anesthesia usage, and powerful regulatory functions of the breathing circuit bags. Furthermore, the rising demand for complex procedures and advanced techniques is expected to grow the market segment at a robust rate during the projected period. However, the masks segment is projected to grow at a considerable rate due to growing awareness, increasing industrialization, and rising pollution levels in the country.
The key players competing in the Canada respiratory devices market are Masimo Corporation; Medtronic plc; ResMed Inc.; Philips Healthcare; and GE Healthcare. The Companies are engaging in vigorous acquisitions, collaborations, and ventures to consolidate their position in the market.